Olema Pharmaceuticals, Inc.
OLMA
$4.42
$0.163.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -25.38% | -60.71% | -51.19% | -9.49% | -2.27% |
| Total Depreciation and Amortization | 31.82% | 5.56% | -5.05% | -12.00% | -9.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 107.61% | 20.51% | 12.32% | -30.48% | -47.92% |
| Change in Net Operating Assets | -62.51% | 177.11% | 80.31% | 22.58% | 230.71% |
| Cash from Operations | -42.26% | -18.78% | -24.59% | -15.23% | 6.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -270.12% | 280.43% | -134.52% | -153.47% | -287.26% |
| Cash from Investing | -270.12% | 280.53% | -134.56% | -153.88% | -289.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 88,521.20% | -99.93% | 663.78% | 3,985.45% | 3.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,807.50% | 100.00% | -- | -- | -- |
| Cash from Financing | 46,611.28% | -99.93% | 663.83% | 3,909.55% | 91.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 311.98% | -76.96% | -182.35% | -302.25% | -1,475.37% |